Latest Advances

  • Condition: Non-Hodgkin Lymphoma
  • Journal: Clinical lymphoma, myeloma & leukemia
  • Treatment Used: 20% Subcutaneous Immunoglobulin Replacement Therapy
  • Number of Patients: 15
  • Published —
The study researched the outcomes of 20% subcutaneous immunoglobulin replacement therapy for patients with non-Hodgkin lymphoma.
Showing 1-2 of 2